Peregrine Capital Management LLC Neurocrine Biosciences Inc Transaction History

Peregrine Capital Management LLC

$3.18 Billion
Q3 2024

A detailed history of Peregrine Capital Management LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Peregrine Capital Management LLC holds 63,681 shares of NBIX stock, worth $7.48 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

63,681

Previous 67,657 5.88%

Holding current value

$7.48 Million

Previous $9.31 Million 21.29%

% of portfolio

0.23%

Previous 0.28%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$114.58 - $153.15 $455,570 - $608,924	-3,976 Reduced 5.88%	63,681 $7.33 Million
Q2 2024 Jul 29, 2024	BUY	$130.86 - $143.19 $115,287 - $126,150	881 Added 1.32%	67,657 $9.31 Million
Q1 2024 Apr 26, 2024	SELL	$130.4 - $143.74 $87,628 - $96,593	-672 Reduced 1.0%	66,776 $9.21 Million
Q4 2023 Jan 26, 2024	SELL	$106.07 - $132.76 $1.23 Million - $1.54 Million	-11,625 Reduced 14.7%	67,448 $8.89 Million
Q3 2023 Oct 19, 2023	SELL	$94.02 - $117.1 $1.34 Million - $1.67 Million	-14,298 Reduced 15.31%	79,073 $8.9 Million
Q2 2023 Jul 26, 2023	BUY	$89.53 - $104.87 $783,745 - $918,031	8,754 Added 10.35%	93,371 $8.8 Million
Q1 2023 Apr 26, 2023	BUY	$94.11 - $123.02 $1.57 Million - $2.05 Million	16,663 Added 24.52%	84,617 $8.56 Million
Q4 2022 Jan 10, 2023	SELL	$106.72 - $127.06 $1.9 Million - $2.26 Million	-17,780 Reduced 20.74%	67,954 $8.12 Million
Q3 2022 Oct 26, 2022	SELL	$92.03 - $107.81 $513,435 - $601,471	-5,579 Reduced 6.11%	85,734 $9.11 Million
Q2 2022 Jul 20, 2022	SELL	$75.79 - $100.07 $5,456 - $7,205	-72 Reduced 0.08%	91,313 $8.9 Million
Q1 2022 Apr 27, 2022	SELL	$72.45 - $94.81 $474,764 - $621,289	-6,553 Reduced 6.69%	91,385 $8.57 Million
Q4 2021 Jan 31, 2022	BUY	$79.65 - $106.22 $7.8 Million - $10.4 Million	97,938 New	97,938 $8.34 Million

Others Institutions Holding NBIX

# of Institutions

623

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.2B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.

Account

Peregrine Capital Management LLC Neurocrine Biosciences Inc Transaction History